Neelum Pharmaceutics Ltd in Birmingham, B43 6PL

Description

Data updated on: 01-11-2023

This company referred to as Neelum Pharmaceutics was started on 2011-01-31 as a Private Limited Company. This firm's head office can be reached at Birmingham on 28a Queslett Road. Assuming you want to reach the business by post, its post code is B43 6PL. The office registration number for Neelum Pharmaceutics Ltd is 07510787. This firm's Standard Industrial Classification Code is 86900: Other human health activities. Neelum Pharmaceutics Limited released its latest accounts for the financial period up to 2023-01-31. The company's most recent confirmation statement was submitted on 2023-02-20.

Azima S. is the following enterprise's solitary director, that was assigned this position in 2011 in January.

Azima S. is the individual who has control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-01-31	2013-01-31	2014-01-31	2015-01-31	2016-01-31	2017-01-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	16 895	14 994	15 376	7 728	7 866	7 443

Balance Sheet
Cash Bank In Hand	13 321	10 988	15 274	11 271	10 773	8 767
Current Assets	13 321	10 988	15 274	11 271	10 773	8 767
Intangible Fixed Assets	8 000	6 000	4 000	2 000
Net Assets Liabilities Including Pension Asset Liability	16 895	14 994	15 376	7 728	7 866	7 443
Tangible Fixed Assets	7 996	5 997	3 998	1 999	1 599

Capital & Reserves
Called Up Share Capital	10	10	10	10	10	10
Profit Loss Account Reserve	16 885	14 984	15 366	7 718	7 856	7 433
Shareholder Funds	16 895	14 994	15 376	7 728	7 866	7 443

Other Financial Data
Creditors Due Within One Year Total Current Liabilities	12 388
Fixed Assets	15 996	11 997	7 998	3 999	1 599
Intangible Fixed Assets Additions	10 000
Intangible Fixed Assets Aggregate Amortisation Impairment	2 000	4 000	6 000	8 000	10 000
Intangible Fixed Assets Amortisation Charged In Period	2 000	2 000	2 000	2 000	2 000
Intangible Fixed Assets Cost Or Valuation	10 000	10 000	10 000	10 000	10 000
Net Current Assets Liabilities	899	2 997	7 378	3 729	6 782	7 958
Tangible Fixed Assets Additions	9 995
Tangible Fixed Assets Cost Or Valuation	9 995	9 995	9 995	9 995	9 995
Tangible Fixed Assets Depreciation	1 999	3 998	5 997	7 996	8 396
Tangible Fixed Assets Depreciation Charge For Period	1 999
Total Assets Less Current Liabilities	16 895	14 994	15 376	7 728	8 381	7 958
Accruals Deferred Income Within One Year	500	500	500	600
Creditors Due Within One Year	12 422	7 991	7 896	7 542	3 991	809
Number Shares Allotted	10	10	10	10	10	10
Other Creditors Due Within One Year	7 658	2 832	1 667	535
Par Value Share	1	1	1	1	1	1
Accruals Deferred Income					515	515
Share Capital Allotted Called Up Paid	10	10	10	10	10	10
Tangible Fixed Assets Depreciation Charged In Period		1 999	1 999	1 999	400
Tangible Fixed Assets Disposals						1 599
Taxation Social Security Due Within One Year	4 264	4 659	5 729	6 407

Company staff

Azima S.

Role: Director

Appointed: 31 January 2011

Latest update: 12 April 2024

People with significant control

Azima S.

Notified on 9 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Azima S.

Notified on 6 April 2016

Ceased on 1 July 2023

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	31 October 2024
Account last made up date	31 January 2023
Confirmation statement next due date	05 March 2024
Confirmation statement last made up date	20 February 2023

Annual Accounts 31 October 2013
Start Date For Period Covered By Report	2012-02-01
End Date For Period Covered By Report	2013-01-31
Date Approval Accounts	31 October 2013
Annual Accounts
Start Date For Period Covered By Report	2013-02-01
End Date For Period Covered By Report	2014-01-31
Annual Accounts 30 October 2015
Start Date For Period Covered By Report	2014-02-01
End Date For Period Covered By Report	2015-01-31
Date Approval Accounts	30 October 2015
Annual Accounts 13 October 2016
Start Date For Period Covered By Report	2015-02-01
Date Approval Accounts	13 October 2016
Annual Accounts
Start Date For Period Covered By Report	2016-02-01
Annual Accounts
Start Date For Period Covered By Report	1 February 2018
End Date For Period Covered By Report	31 January 2019
Annual Accounts
Start Date For Period Covered By Report	1 February 2019
End Date For Period Covered By Report	31 January 2020
Annual Accounts
Start Date For Period Covered By Report	1 February 2020
End Date For Period Covered By Report	31 January 2021
Annual Accounts
Start Date For Period Covered By Report	1 February 2021
End Date For Period Covered By Report	31 January 2022
Annual Accounts
Start Date For Period Covered By Report	1 February 2022
End Date For Period Covered By Report	31 January 2023
Annual Accounts
Start Date For Period Covered By Report	1 February 2023
End Date For Period Covered By Report	31 January 2024
Annual Accounts
End Date For Period Covered By Report	2016-01-31
Annual Accounts
End Date For Period Covered By Report	2017-01-31
Annual Accounts
End Date For Period Covered By Report	31 January 2018
Annual Accounts 28 October 2014
Date Approval Accounts	28 October 2014
Annual Accounts 31 October 2017
Date Approval Accounts	31 October 2017

Neelum Pharmaceutics Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Azima S.

Basheer A.

People with significant control

Azima S.

Azima S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode